Cramer Reevaluates Opko Health
When asked about Opko Health on September 30, Cramer said the $1.3 billion drug and diagnostics company made sense as a trade, but not as an investment.
The "Mad Money" host is always willing to reconsider his views, though, especially when a CEO is willing to come on the program and make the case for his company . So Cramer was happy to have Dr. Phillip Frost, chairman and CEO of Opko Health, on the program Thursday. Watch the video to see the conversation.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the Mad Money website? firstname.lastname@example.org